Form 8-K - Current report:
SEC Accession No. 0001437749-24-035304
Filing Date
2024-11-14
Accepted
2024-11-14 16:10:16
Documents
16
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20241114_8k.htm   iXBRL 8-K 25467
2 EXHIBIT 99.1 ex_748191.htm EX-99.1 94917
7 atxilogo.jpg GRAPHIC 15219
  Complete submission text file 0001437749-24-035304.txt   278015

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20241114.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20241114_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20241114_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20241114_pre.xml EX-101.PRE 11585
18 EXTRACTED XBRL INSTANCE DOCUMENT atxi20241114_8k_htm.xml XML 2847
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 241462192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)